We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
+6.46%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$92.1M
AUM Growth
+$9.88M
Cap. Flow
+$5.78M
Cap. Flow %
6.28%
Top 10 Hldgs %
95.14%
Holding
26
New
6
Increased
10
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
SCYX icon
SCYNEXIS
SCYX
+$8.4M
2
ICMB icon
Investcorp Credit Management BDC
ICMB
+$6.09M
3
UHAL icon
U-Haul Holding Co
UHAL
+$960K
4
PCG icon
PG&E
PCG
+$955K
5
GARS
Garrison Capital Inc.
GARS
+$936K

Top Sells

Rank Stock Value
1
KALA icon
KALA BIO
KALA
+$10.1M
2
SBBP
Strongbridge Biopharma plc.
SBBP
+$1.04M
3
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
+$214K
4
ADNT icon
Adient
ADNT
+$60K
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$51.7K

Sector Composition

Rank Sector Weight
1 Healthcare 69.65%
2 Financials 10.36%
3 Real Estate 1.51%
4 Utilities 1.07%
5 Industrials 1.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
26
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$787B
– –
-2,519
Closed -$672K
1
2

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q1 2018 Portfolio in Review

As of Q1 2018, Caxton Corporation held 26 positions worth $92.1M, up 12% from $82.3M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Caxton Corporation deployed $5.78M of net new capital in Q1 2018, opening 6 new positions and adding to 10 existing holdings. Its largest new stake was SCYNEXIS: 60,880 shares worth $6.53M.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 76% a quarter earlier, followed by Financials and Real Estate.

On the sell side, the largest reduction was Strongbridge Biopharma plc., an estimated $1.04M trimmed.

  • Caxton Corporation's largest Q1 2018 buy was SCYNEXIS: 60,880 shares worth $6.53M.
  • Caxton Corporation added most to Investcorp Credit Management BDC in Q1 2018, an estimated $6.09M increase.
  • Caxton Corporation's biggest Q1 2018 reduction was Strongbridge Biopharma plc., cutting an estimated $1.04M.
  • Caxton Corporation fully exited KALA BIO in Q1 2018, selling an estimated $10.1M.
  • Caxton Corporation's ten largest holdings make up 95% of its $92.1M portfolio in Q1 2018.
  • Caxton Corporation opened 6 new positions and closed 3 in Q1 2018.
  • Caxton Corporation's portfolio value rose 12% quarter-over-quarter to $92.1M.

Based on Caxton Corporation's 13F filing for Q1 2018, filed 15 May 2018.